SightGlass Vision Announces R&D Webinar Featuring Leading Myopia Experts

SightGlass Vision announced it will hold an R&D webinar to discuss the science of and latest research in myopia, as well as provide an overview about the clinical development and commercialization program for the company’s novel glasses designed to slow the progression of myopia in children.

Joining SightGlass Vision’s Company leadership will be two of the world’s foremost leaders in myopia research and management: Earl L. Smith III, OD, PhD, FAAO, FARVO, Greeman-Petty Professor, Vision Department and Interim Chief Health Officer, University of Houston, Texas; and Jay Neitz, PhD, Professor and Research Director, Department of Ophthalmology, and Co-director, Neitz Lab, University of Washington, and co-founder of SightGlass Vision.

“We have been working hard on treatment options and are proud of the great progress we have made in a short period of time. We are honored to be joined by two of the top leaders in myopia and vision science research, Earl Smith and Jay Neitz, who will help shine a light on this serious eye condition. In addition to providing an overview of myopia and the discovery of a unique mechanism of action to treat the condition, we look forward to discussing the clinical development and latest data from our CYPRESS pivotal trial of our novel lenses designed to slow myopia progression in children,” Thomas W. Chalberg, PhD, Founder and Chief Executive Officer, said in a company news release.

The SightGlass Vision R&D webinar will be held on Wednesday, May 20, 2020, from 9:00-11:30 AM ET. Participation is limited. The webinar will be available live for registered participants; it will not be available in archived form. To register, visit https://platformwebcast.com/sightglassvision/.